Fresenius Kabi Logo (Pot0x 0002 01)
Potassium Acetate Injection, Solution, Concentrate
Product Images NDC 65219-510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Acetate (NDC 65219-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label (Principal Display Panel – Potassium Acetate Injection, USP 20 mL Vial Label)
This text appears to be a description of a medication contained in a vial with NDC 85219-510-02. The solution inside contains 196 mg of potassium acetate per milliliter with a pH level of 6.2. It may also contain acetic acid for pH adjustment. The medication is sterile, nonpyrogenic, and must be diluted before intravenous use. It is advised to check for clarity and integrity of the seal before use. The medication does not contain aluminum above a specific concentration. It is manufactured by Fresenius Kabi and is a single-dose injection. For detailed instructions and usage, it is recommended to refer to the package insert or consult healthcare professionals.*
Package Label (Principal Display Panel – Potassium Acetate Injection, USP 20 mL Tray Label)
This text is a product label for a medication named Potassium Acetate Injection, USP. It contains 40 mEq of potassium acetate per 20 mL vial and is meant for intravenous use after being diluted. Each milliliter contains 196 mg of potassium acetate and may also contain acetic acid for pH adjustment. The solution has a calculated osmolality of 4mOsmol/mL and a pH range of 5.5 to 8.0. The usual dose and administration instructions can be found in the insert. It is sterile, nonpyrogenic, and should be added aseptically to a suitable intravenous solution. The product should be stored at room temperature and discarded if the seal is damaged or if it's not clear. This information is provided by Fresenius Kabi, a pharmaceutical company based in Lake Zurich, IL.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
